Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.025 1.03% 2.45 2.40 2.50 2.45 2.375 2.43 9,110,768 12:48:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.1 -0.0 - 80

Sareum Share Discussion Threads

Showing 11951 to 11974 of 12575 messages
Chat Pages: Latest  479  478  477  476  475  474  473  472  471  470  469  468  Older
DateSubjectAuthorDiscuss
09/11/2020
17:03
Hope to see who's been accumulating very soon
horridhenry
09/11/2020
16:42
Thanks, appreciate the response. More large buys coming through by the looks of it, like you say someone is accumulating a large amount of shares in SAR and the Covid news hastn stopped them. RNS this week? been a while.
whiskey9
09/11/2020
16:24
Pfizer have gaps in their Cancer/immunology related portfolio of new drugs in research. Sareum has never been about Covid which had the potential for short term gains. The potential is already there for all to see Clearly the buyer/'s accumulating are not in it for the Covid dividend
horridhenry
09/11/2020
16:07
Why Pfizer? why now?
whiskey9
09/11/2020
15:34
looking at the trades there are more than the usual number of late reported 500k & 1M buys. if recent history is anything to go by then there will be a load of huge trades reported tomorrow after hours. Happy days for whoever it is quietly accumulating Hope its Pfizer !!?
horridhenry
09/11/2020
14:50
>>>norma, held for years, bought bulk sub 0.4p LOL
kris akabusi
09/11/2020
13:57
Sentiment will shake out the day traders and quick buck merchants, but LTH’s will remain
curriedquaker
09/11/2020
13:48
No but sentiment has
mw16
09/11/2020
13:44
The fundamentals of Sareum going forward have not changed with the news from Pfizer.
curriedquaker
09/11/2020
13:40
Time to buy a few more. I always said that I would buy back in at 1.50 so time to commit
curriedquaker
09/11/2020
13:38
Sareum are primarily involved with treatments for cancer. Suggest folks have a look at the finals dated 13 October to see just how many irons Sareum have in the fire! Covid-19 research is a promising sideline.
rich1952
09/11/2020
13:25
kris akabusi - “covid vaccine cos that's our only iron in the fire‘ My spider senses tell me that you bought here without conducting any research didn’t you? LOL
norma_stitts
09/11/2020
13:18
Sareum Go back 0.9p?
zxie
09/11/2020
12:55
There are over 40000 on this trial worldwide and they expect to produce the results from all by end of November. The scientists being interviewed though are down playing it all and not getting carried away.
silvergreyhead1
09/11/2020
12:46
Ah so called covid vaccine 43k given the vaccine and ten percent got covid. But so far not known if they were all given covid after injection. Its a bit of a mes so far.
vikingwarrier
09/11/2020
12:45
That will have triggered a lot of stop losses I suspect.... DL
davidlloyd
09/11/2020
12:36
covid vaccine cos that's our only iron in the fire
kris akabusi
09/11/2020
12:35
Why the drop?
bobby.ifa
09/11/2020
12:30
Sar now irrelevant
mw16
09/11/2020
02:01
I don’t think it’ll be too long before we start getting some holding RNS’s (plural) popping up.
norma_stitts
06/11/2020
15:30
Yesterday I whizzed through the 10- Q of Sierra to see what if anything they said on SRA737. This was in light of comments that Tim made in the October 16 presentation that Sierra had a new CEO and Business Development person and there were indications of a change in approach. They said not very much as I would have expected. We had this on the bottom of Page 22. This is identical to what they said in August for the H1 10-Q. It will be interesting to see if there is a change in the wording when they present in early Feb for Q4 10-Q. quote We are exploring options to support the potential continued development of SRA737 in the future. There can be no assurance that we will successfully obtain the funding or support necessary to advance SRA737 or obtain such funding or support on commercially reasonable terms unquote In the discussion on corporate R&D expenditure in Q3 they stated that quote These increases were partially offset by a $1.5 million decrease in clinical trial, third-party manufacturing, research and preclinical costs for SRA737.unquote
cerrito
06/11/2020
15:21
https://twitter.com/hybridanllp/status/1324664823775481857?s=21 Interesting tweet from Hybridan concerning Sareum, hopefully it will spark more interest.
curriedquaker
06/11/2020
14:58
This may have been posted before but there are written answers to 33 questions asked. As can be expected the answers are not all that revealing-both for legal reasons and fact that there is much uncertainty. The main thing for me are delays in SDC-1802. hxxps://www.investormeetcompany.com/investor/meeting/final-results-for-the-year-ended-30th-june-12020
cerrito
05/11/2020
19:42
IT'S A CON - IT'S A DUD, What a wan/er, you've all been had! BB8 IN BB8 WE TRUST.
big brother8
Chat Pages: Latest  479  478  477  476  475  474  473  472  471  470  469  468  Older
ADVFN Advertorial
Your Recent History
LSE
SAR
Sareum
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210512 14:37:34